Wednesday, February 10, 2010, 2:56PM AEST - The Australian Stockmarket closes in 1 hour and 9 minutes.
To create a watchlist or portfolio of shares, Register

InterMune Inc. (ITMN)

 8:00AM AEST: 15.60 USD  Up 0.10 (0.65%)  
 MORE ON ITMN 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 InterMune, Inc. (NasdaqNM:ITMN) Delayed quote dataEdit
Last Trade:15.60 USD
Trade Time: 8:00AM AEST
Change:Up 0.10 (0.65%)
Prev Close:15.50
Open:15.94
Bid:N/A
Ask:17.33 x 500
1y Target Est:20.45
Day's Range:15.50 - 16.05
52wk Range:10.48 - 19.12
Volume:850,326
Avg Vol (3m):748,598
Market Cap:728.04M
P/E (ttm):N/A
EPS (ttm):-2.64
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add ITMN to Portfolio   Download Data

 HEADLINES 
•Biotech ETFs Immune To Broad Selling
Investor's Business Daily (Tue 9:34AM)
•Three Stocks The Insiders Love
at Investopedia (Sat, Feb 6)
•[$$] Pericom, PetroQuest, Kulicke & Soffa Jump
at The Wall Street Journal Online (Tue, Feb 2)
•Big Week For Pharma
at CNBC (Tue, Feb 2)
•[video] Take Your Position: Pharma's Big Week
at CNBC (Tue, Feb 2)
•Monday Options Recap
at Seeking Alpha (Tue, Feb 2)
•InterMune call volume pops ahead of FDA panel
at Reuters (Tue, Feb 2)
•InterMune gets March FDA review for lung drug
AP (Tue, Feb 2)
•InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
PR Newswire (Tue, Feb 2)
•Insider Trading Continues to Reflect Weak Recovery
at Seeking Alpha (Mon, Feb 1)
•INTERMUNE INC Files SEC form 8-K, Other Events
EDGAR Online (Sat, Jan 30)
•Deathbed Stocks Revisited
at Motley Fool (Sat, Jan 30)
More Headlines for ITMN...
 ANALYST 
EPS Est (next year) (Dec-09) :-2.69
EPS Est (in 2 years) (Dec-10) :-2.31
Avg Rec (current)*:2.2
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
InterMune, Inc., a biotechnology company, focuses on the research, development, and commercialization of therapies in pulmonology and hepatology. It offers Actimmune for the treatment of patients with severe, malignant osteopetrosis, and chronic g...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices